These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 25124262)

  • 1. Comment on: "Current status and trends in performance-based risk-sharing arrangements between healthcare payers and medical product manufacturers".
    Curto A; Garattini L
    Appl Health Econ Health Policy; 2014 Oct; 12(5):565. PubMed ID: 25124262
    [No Abstract]   [Full Text] [Related]  

  • 2. Authors' reply to Curto and Garattini: "Current status and trends in performance-based risk-sharing arrangements between healthcare payers and medical product manufacturers".
    Carlson JJ; Gries K; Yeung K; Sullivan SD; Garrison LP
    Appl Health Econ Health Policy; 2014 Oct; 12(5):567-8. PubMed ID: 25124263
    [No Abstract]   [Full Text] [Related]  

  • 3. Current status and trends in performance-based risk-sharing arrangements between healthcare payers and medical product manufacturers.
    Carlson JJ; Gries KS; Yeung K; Sullivan SD; Garrison LP
    Appl Health Econ Health Policy; 2014 Jun; 12(3):231-8. PubMed ID: 24664994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance-based risk-sharing arrangements-good practices for design, implementation, and evaluation: report of the ISPOR good practices for performance-based risk-sharing arrangements task force.
    Garrison LP; Towse A; Briggs A; de Pouvourville G; Grueger J; Mohr PE; Severens JL; Siviero P; Sleeper M
    Value Health; 2013; 16(5):703-19. PubMed ID: 23947963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Private sector risk-sharing agreements in the United States: trends, barriers, and prospects.
    Garrison LP; Carlson JJ; Bajaj PS; Towse A; Neumann PJ; Sullivan SD; Westrich K; Dubois RW
    Am J Manag Care; 2015 Sep; 21(9):632-40. PubMed ID: 26618366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk-sharing arrangements that link payment for drugs to health outcomes are proving hard to implement.
    Neumann PJ; Chambers JD; Simon F; Meckley LM
    Health Aff (Millwood); 2011 Dec; 30(12):2329-37. PubMed ID: 22147861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging roles for pharmacists in performance-based risk-sharing arrangements.
    Calabrese MJ; Cooke CE; Watson K; de Bittner MR
    Am J Health Syst Pharm; 2017 Jul; 74(13):1007-1012. PubMed ID: 28522641
    [No Abstract]   [Full Text] [Related]  

  • 8. When do performance-based risk-sharing arrangements make sense?
    Drummond M
    Eur J Health Econ; 2015 Jul; 16(6):569-71. PubMed ID: 25783211
    [No Abstract]   [Full Text] [Related]  

  • 9. Can't get no satisfaction? Will pay for performance help?: toward an economic framework for understanding performance-based risk-sharing agreements for innovative medical products.
    Towse A; Garrison LP
    Pharmacoeconomics; 2010; 28(2):93-102. PubMed ID: 20085386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Financial valuation of incentive arrangements in managed care contracts: a real options approach.
    Maurer RT
    J Health Care Finance; 2001; 28(1):39-60. PubMed ID: 11669292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance-based risk-sharing agreements in renal care: current experience and future prospects.
    Drummond M; Federici C; Busink E; Apel C; Kendzia D; Brouwer W
    Expert Rev Pharmacoecon Outcomes Res; 2021 Apr; 21(2):197-209. PubMed ID: 33439090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance-Based Risk-Sharing Arrangements (PBRSA): Is it a Solution to Increase Bang for the Buck for Pharmaceutical Reimbursement Strategy for Our Nation and Around the World?
    Kim AE; Choi DH; Chang J; Kim SH
    Clin Drug Investig; 2020 Dec; 40(12):1107-1113. PubMed ID: 33037566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers.
    Adamski J; Godman B; Ofierska-Sujkowska G; Osińska B; Herholz H; Wendykowska K; Laius O; Jan S; Sermet C; Zara C; Kalaba M; Gustafsson R; Garuolienè K; Haycox A; Garattini S; Gustafsson LL
    BMC Health Serv Res; 2010 Jun; 10():153. PubMed ID: 20529296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance-based risk-sharing arrangements for devices and diagnostics in the United States: a systematic review.
    Chen Y; Carlson JJ
    J Manag Care Spec Pharm; 2022 Jan; 28(1):78-83. PubMed ID: 34949115
    [No Abstract]   [Full Text] [Related]  

  • 15. Reforming the primary care physician payment system: eliminating E & M codes and creating the financial incentives for an "advanced medical home".
    Goldfield N; Averill R; Vertrees J; Fuller R; Mesches D; Moore G; Wasson JH; Kelly W
    J Ambul Care Manage; 2008; 31(1):24-31. PubMed ID: 18162792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance-Based Risk-Sharing Arrangements: An Updated International Review.
    Carlson JJ; Chen S; Garrison LP
    Pharmacoeconomics; 2017 Oct; 35(10):1063-1072. PubMed ID: 28695544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is hospital capitation DOA?
    Gish R
    Healthc Financ Manage; 1999 Apr; 53(4):39-40. PubMed ID: 10557977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Innovating in pharmaceutical expenditure management: from payment per product to payment for health outcomes].
    Espín J
    Rev Esp Salud Publica; 2013; 87(4):303-6. PubMed ID: 24100769
    [No Abstract]   [Full Text] [Related]  

  • 19. Where are we on "risk-sharing" agreements?
    Neumann PJ
    Value Health; 2013; 16(5):701-2. PubMed ID: 23947962
    [No Abstract]   [Full Text] [Related]  

  • 20. [Risk sharing methods in middle income countries].
    Inotai A; Kaló Z
    Acta Pharm Hung; 2012; 82(1):43-52. PubMed ID: 22570986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.